Man Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$1.35M Buy
2024
Q3
$1.56M Buy
2023
Q4
Hold
2023
Q3
Hold
2023
Q2
Hold
2023
Q1
Hold
2021
Q3
Sell
2021
Q2
$492K Buy
2018
Q3
Sell
2018
Q2
$1.22M Sell
2018
Q1
$1.37M Buy